BioTrends Announces Newly Expanded Oncology Division to Focus on Launch Metrics of Bristol-Myers Squibb`s Yervoy, Roche and Daiichi Sankyo, Inc`s Zelboraf, Pfizer`s Xalkori and Johnson & Johnson`s Zytiga